2022 annual financial data
Scinai Immunotherapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -11,061,000 USD and net income was -5,796,000 USD.
Operating cash flow was -7,265,000 USD.
Get free Scinai Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,061,000 USD
- Net income
- -5,796,000 USD
- Operating cash flow
- -7,265,000 USD